EcoDrugPlus

Collagenase 3-Like

Ensembl ID : ENSAMXG00000006427
Gene Symbol: LOC103041846
2 Cross references
301 Possible Orthologues:

Colony Stimulating Factor 1 Receptor, A

Ensembl ID : ENSAMXG00000017088
Gene Symbol: CSF1RA
1 Cross references
207 Possible Orthologues:

Complement C1s Subcomponent-Like

Ensembl ID : ENSAMXG00000031584
Gene Symbol: LOC111188209
3 Cross references
161 Possible Orthologues:

Complement C1s Subcomponent-Like

Ensembl ID : ENSAMXG00000032678
Gene Symbol: LOC103027368
3 Cross references
161 Possible Orthologues:

Complement Factor D-Like

Ensembl ID : ENSAMXG00000038575
Gene Symbol: LOC103044529
3 Cross references
134 Possible Orthologues:

Corticotropin Releasing Hormone Receptor 1

Ensembl ID : ENSAMXG00000036167
Gene Symbol: CRHR1
3 Cross references
203 Possible Orthologues:

Corticotropin Releasing Hormone Receptor 1

Ensembl ID : ENSAMXG00000038656
Gene Symbol: CRHR1
3 Cross references
183 Possible Orthologues:

Cyclin D1

Ensembl ID : ENSAMXG00000043726
Gene Symbol: CCND1
3 Cross references
232 Possible Orthologues:

Cyclin Dependent Kinase 1

Ensembl ID : ENSAMXG00000020354
Gene Symbol: CDK1
3 Cross references
246 Possible Orthologues:

Cyclin Dependent Kinase 2

Ensembl ID : ENSAMXG00000030741
Gene Symbol: CDK2
3 Cross references
203 Possible Orthologues:

Cyclin Dependent Kinase 4

Ensembl ID : ENSAMXG00000043568
Gene Symbol: CDK4
3 Cross references
239 Possible Orthologues:

Cyclin Dependent Kinase 5

Ensembl ID : ENSAMXG00000013249
Gene Symbol: CDK5
3 Cross references
169 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).